HUTCHMED (China) (0013) Stock Forecast & Price Target

Compare

7 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0013 Analyst Ratings

Strong Buy

8 Buy

0 Hold

1 Sell

Based on 9 analysts giving stock ratings to

HUTCHMED

(China)

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0013 Stock 12 Month Forecast

Average Price Target

HK$32.30

▲(38.88% Upside)

Based on 9 Wall Street analysts offering 12 month price targets for HUTCHMED (China) in the last 3 months. The average price target is HK$32.30 with a high forecast of HK$38.06 and a low forecast of HK$21.66. The average price target represents a 38.88% change from the last price of HK$23.26.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"HK$20","39":"HK$39","24.75":"HK$24.8","29.5":"HK$29.5","34.25":"HK$34.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38.0621844239936,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$38.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.3023721787,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$32.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.6630517732304,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$21.66</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,24.75,29.5,34.25,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.12,26.115552647999507,27.111105295999018,28.106657943998524,29.10221059199803,30.09776323999754,31.093315887997047,32.08886853599655,33.084421183996064,34.079973831995574,35.07552647999508,36.07107912799459,37.0666317759941,{"y":38.0621844239936,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.12,25.672490167592308,26.224980335184615,26.77747050277692,27.329960670369232,27.88245083796154,28.434941005553846,28.987431173146152,29.53992134073846,30.09241150833077,30.644901675923073,31.197391843515383,31.74988201110769,{"y":32.3023721787,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.12,24.854080905633108,24.588161811266215,24.322242716899325,24.05632362253243,23.79040452816554,23.524485433798645,23.258566339431756,22.992647245064862,22.72672815069797,22.460809056331076,22.194889961964186,21.928970867597293,{"y":21.6630517732304,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":34.65,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.65,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.65,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.45,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.55,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.75,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.1,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.2,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.6,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":23.55,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":27.3,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.46,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.12,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetHK$38.06

Average Price TargetHK$32.30

Lowest Price TargetHK$21.66

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Bryce Generon

TR | OpenAI - 4o

HK$27→HK$25

Hold

7.48%

Upside

Reiterated

10/11/25

AI Generated ArticleAI Generated Article

Jack Lin

Morgan Stanley

HK$28→HK$21.4

Sell

-8.00%

Downside

Downgraded

09/22/25

Morgan Stanley downgrades HUTCHMED (China) (HCM) to a SellMorgan Stanley analyst Jack Lin downgraded Hutchmed China Ltd (13:HK) from Equalweight to Underweight with a price target of HK$21.40 (from HK$28.00).

Unknown Analyst

CICC

Not Ranked

CICC

HK$30

Buy

28.98%

Upside

Reiterated

08/13/25

Jill Wu

CMB International Securities

HK$34.03→HK$31.39

Buy

34.95%

Upside

Reiterated

08/11/25

HUTCHMED (China) Buy Rating: Strategic Growth Amidst Market Challenges

Wangbin Zhou

Citi

HK$42→HK$36

Buy

54.77%

Upside

Reiterated

08/11/25

Citi Remains a Buy on HUTCHMED (China) (HCM)

Unknown Analyst

Daiwa

Not Ranked

Daiwa

HK$30

Buy

28.98%

Upside

Reiterated

08/11/25

Unknown Analyst

BOCOM International Holdings Company

Not Ranked

BOCOM International Holdings Company

HK$37.6

Buy

61.65%

Upside

Reiterated

08/08/25

Unknown Analyst

CLSA

Not Ranked

CLSA

HK$31.4

Buy

35.00%

Upside

Reiterated

08/08/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

HK$32.5

Buy

39.72%

Upside

Reiterated

08/08/25

Unknown Analyst

UBS

Not Ranked

UBS

HK$36.9

Buy

58.64%

Upside

Reiterated

08/07/25

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$30

Buy

28.98%

Upside

Reiterated

06/27/25

Unknown Analyst

China Merchants Securities

Not Ranked

China Merchants Securities

HK$62.8

Buy

169.99%

Upside

Reiterated

06/04/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$33.01

Buy

41.92%

Upside

Reiterated

03/21/25

Unknown Analyst

BOCOM International Holdings Company

Not Ranked

BOCOM International Holdings Company

HK$44

Buy

89.17%

Upside

Reiterated

03/20/25

Unknown Analyst

Bank of China

Not Ranked

Bank of China

HK$23.9

Buy

2.75%

Upside

Reiterated

03/20/25

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Bryce Generon

TR | OpenAI - 4o

HK$27→HK$25

Hold

7.48%

Upside

Reiterated

10/11/25

AI Generated ArticleAI Generated Article

Jack Lin

Morgan Stanley

HK$28→HK$21.4

Sell

-8.00%

Downside

Downgraded

09/22/25

Unknown Analyst

CICC

Not Ranked

CICC

HK$30

Buy

28.98%

Upside

Reiterated

08/13/25

Jill Wu

CMB International Securities

HK$34.03→HK$31.39

Buy

34.95%

Upside

Reiterated

08/11/25

HUTCHMED (China) Buy Rating: Strategic Growth Amidst Market Challenges

Wangbin Zhou

Citi

HK$42→HK$36

Buy

54.77%

Upside

Reiterated

08/11/25

Citi Remains a Buy on HUTCHMED (China) (HCM)

Unknown Analyst

Daiwa

Not Ranked

Daiwa

HK$30

Buy

28.98%

Upside

Reiterated

08/11/25

Unknown Analyst

BOCOM International Holdings Company

Not Ranked

BOCOM International Holdings Company

HK$37.6

Buy

61.65%

Upside

Reiterated

08/08/25

Unknown Analyst

CLSA

Not Ranked

CLSA

HK$31.4

Buy

35.00%

Upside

Reiterated

08/08/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

HK$32.5

Buy

39.72%

Upside

Reiterated

08/08/25

Unknown Analyst

UBS

Not Ranked

UBS

HK$36.9

Buy

58.64%

Upside

Reiterated

08/07/25

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$30

Buy

28.98%

Upside

Reiterated

06/27/25

Unknown Analyst

China Merchants Securities

Not Ranked

China Merchants Securities

HK$62.8

Buy

169.99%

Upside

Reiterated

06/04/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$33.01

Buy

41.92%

Upside

Reiterated

03/21/25

Unknown Analyst

BOCOM International Holdings Company

Not Ranked

BOCOM International Holdings Company

HK$44

Buy

89.17%

Upside

Reiterated

03/20/25

Unknown Analyst

Bank of China

Not Ranked

Bank of China

HK$23.9

Buy

2.75%

Upside

Reiterated

03/20/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HUTCHMED (China)

1 Month

xxx

Success Rate

3/6 ratings generated profit

Average Return

+1.28%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.28% per trade.

3 Months

xxx

Success Rate

3/6 ratings generated profit

Average Return

+5.38%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.38% per trade.

1 Year

Jack LinMorgan Stanley

Success Rate

1/1 ratings generated profit

Average Return

+10.60%

downgraded a sell rating last month

Copying Jack Lin's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of +10.60% per trade.

2 Years

xxx

Success Rate

1/6 ratings generated profit

Average Return

-7.97%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -7.97% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0013 Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0013 has received 2 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. 0013 average Analyst price target in the past 3 months is 32.30.

Each month's total comprises the sum of three months' worth of ratings.

0013 Financial Forecast

0013 Earnings Forecast

Next quarter’s earnings estimate for 0013 is HK$3.89 with a range of HK$3.89 to HK$3.89. The previous quarter’s EPS was HK$4.04. 0013 beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 0013 has Outperformed its overall industry.

0013 Sales Forecast

Next quarter’s sales forecast for 0013 is HK$2.54B with a range of HK$2.25B to HK$3.03B. The previous quarter’s sales results were HK$2.16B. 0013 beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 0013 has Outperformed its overall industry.

0013 Stock Forecast FAQ

What is HK:0013’s average 12-month price target, according to analysts?

Based on analyst ratings, HUTCHMED (China) Limited’s 12-month average price target is 32.30.

What is HK:0013’s upside potential, based on the analysts’ average price target?

HUTCHMED (China) Limited has 38.88% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HUTCHMED (China) Limited a Buy, Sell or Hold?

HUTCHMED (China) Limited has a consensus rating of Strong Buy, which is based on 8 buy ratings, 0 hold ratings and 1 sell ratings.

What is HUTCHMED (China) Limited’s share price target?

The average share price target for HUTCHMED (China) Limited is 32.30. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$38.06 ,and the lowest forecast is HK$21.66. The average share price target represents 38.88% Increase from the current price of HK$23.26.

What do analysts say about HUTCHMED (China) Limited?

HUTCHMED (China) Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of HUTCHMED (China) Limited?

To buy shares of HK:0013, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

HUTCHMED (China) (0013) Stock Forecast & Price Target

0013 Analyst Ratings

0013 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering HUTCHMED (China)

0013 Analyst Recommendation Trends

0013 Financial Forecast

0013 Earnings Forecast

0013 Sales Forecast

0013 Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts